FDA updated the warning label on Reclast (zoledronic acid), used to treat osteoporosis, regarding the drug causing acute renal (kidney) failure in high-risk patients. FDA warned to[...]

If you know of a serious adverse drug event (ADE) that warrants follow up by FDA you can go to the following link to file a report. The MedWatch program is intended to gather data [...]

The FDA keeps track of adverse drug events through the Adverse Event Reporting System (AERS). When an adverse event from a drug or therapeutic biologic is suspected, and a report f[...]